Suprelorin 4.7 mg Implant for Dogs and Cats

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Deslorelin

Available from:

Virbac

ATC code:

QH01CA93

INN (International Name):

Deslorelin

Pharmaceutical form:

Implant

Prescription type:

POM-V - Prescription Only Medicine – Veterinarian

Therapeutic group:

Cats, Dogs

Therapeutic area:

Hormone

Authorization status:

Authorized

Authorization date:

2007-07-10

Summary of Product characteristics

Revised: January 2023
AN: 02661/2022
Page 1 of 10
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Suprelorin 4.7 mg implant for dogs and cats
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Deslorelin (as deslorelin acetate)
4.7 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Implant.
White to pale yellow cylindrical implant.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dog, cat (male).
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Male dog:
For the induction of temporary infertility in healthy, intact,
sexually mature male dogs.
Prepubertal female dog:
For the induction of temporary infertility to delay the first oestrus
and heat signs, and
to prevent pregnancy at a young age in intact and healthy sexually
immature female
dogs. The implant should be administered between 12 and 16 weeks of
age.
Male cat:
For the induction of temporary infertility and suppression of urine
odour and of sexual
behaviours such as libido, vocalisation, urine marking, and
aggressiveness in intact
male cats from 3 months of age.
4.3
CONTRAINDICATIONS
None.
Revised: January 2023
AN: 02661/2022
Page 2 of 10
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
All target species:
In certain cases, the implant may be lost from a treated animal. If
lack of expected
efficacy is suspected, then the subcutaneous presence of the implant
should be
checked.
Male dog:
Infertility is achieved from 6 weeks up to at least 6 months after
initial treatment.
Treated dogs should therefore still be kept away from bitches on heat
within the first
6 weeks after initial treatment.
One out of 75 dogs treated with the veterinary medicinal product
during clinical trials
mated and tied with a bitch on heat within six months of implantation,
but this did not
result in pregnancy. Should a treated dog mate with a bitch between 6
weeks and 6
months after treatment, appropriate measures should be taken to rule
out the risk of
pregnancy.
In rare cases, suspected lack of expected efficacy has been r